Basic Information
| RNALocate ID: | RLID:11000619 |
| RNA Symbol: | hsa-let-7d-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-let-7d-5p |
| RNA ID: | miRBase:MIMAT0000065 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001219 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001220 | Cytoplasm | Colon cancer cells | 20864815 |
| RLID:01001221 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001222 | Cytoplasm | HeLa cells | 22058130 |
| RLID:01001223 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001224 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001225 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001226 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001227 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001228 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001229 | Nucleus | HeLa cells | 22058130 |
| RLID:11000611 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11000612 | Exosome | Human cervical carcinoma cell line (SiHa) | 25760330 |
| RLID:11000613 | Exosome | Hetastatic gastric cancer cell line (AZ-P7a) | 20949044 |
| RLID:11000614 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11000615 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000616 | Exosome | Breast milk | 22211110 |
| RLID:11000617 | Exosome | Epidermal melanocytes (HEMa-LP) | 23056502 |
| RLID:11000618 | Exosome | Brain tissue | 23382797 |
| RLID:11000620 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11000621 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
| RLID:11000622 | Microvesicle | Plasma | 23077538 |
| RLID:11000623 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11000624 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11000625 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000004 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000264 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-let-7d-5p | Diffuse large b cell lymphoma | MNDR-E-MI-01210 |
| MNDR | hsa-let-7d-5p | Splenic marginal zone lymphoma | MNDR-E-MI-01211 |
| MNDR | hsa-let-7d-5p | Oral squamous cell carcinoma | MNDR-E-MI-01212 |
| MNDR | hsa-let-7d-5p | Lymphoma | MNDR-E-MI-01213 |
| MNDR | hsa-let-7d-5p | Lymphoma non-hodgkin | MNDR-E-MI-01214 |
| MNDR | hsa-let-7d-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-01215 |
| MNDR | hsa-let-7d-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-01216 |
| MNDR | hsa-let-7d-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-01217 |
| MNDR | hsa-let-7d-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-01218 |
| MNDR | hsa-let-7d-5p | Her2-receptor positive breast cancer | MNDR-E-MI-01219 |
| MNDR | hsa-let-7d-5p | Breast cancer luminal | MNDR-E-MI-01220 |
| MNDR | hsa-let-7d-5p | Prostate cancer | MNDR-E-MI-01221 |
| MNDR | hsa-let-7d-5p | Gastric cancer | MNDR-E-MI-01222 |
| MNDR | hsa-let-7d-5p | Gastric lymphoma | MNDR-E-MI-01223 |
| MNDR | hsa-let-7d-5p | Alzheimer disease | MNDR-E-MI-01224 |
| MNDR | hsa-let-7d-5p | Dysautonomia familial | MNDR-E-MI-01225 |
| MNDR | hsa-let-7d-5p | Seizures | MNDR-E-MI-01226 |
| MNDR | hsa-let-7d-5p | Cardiovascular disease | MNDR-E-MI-01227 |
| MNDR | hsa-let-7d-5p | Carotid stenosis | MNDR-E-MI-01228 |
| MNDR | hsa-let-7d-5p | Lung cancer | MNDR-E-MI-01229 |
| MNDR | hsa-let-7d-5p | Metabolic syndrome x | MNDR-E-MI-01230 |
| MNDR | hsa-let-7d-5p | Parkinson disease | MNDR-E-MI-01231 |
| MNDR | hsa-let-7d-5p | Breast cancer | MNDR-E-MI-01232 |
| MNDR | hsa-let-7d-5p | Pancreatic cancer | MNDR-E-MI-01233 |
| MNDR | hsa-let-7d-5p | Melanoma | MNDR-E-MI-01234 |
| MNDR | hsa-let-7d-5p | Nephroblastoma | MNDR-E-MI-01235 |
| MNDR | hsa-let-7d-5p | Colon cancer | MNDR-E-MI-01236 |
| MNDR | hsa-let-7d-5p | Ischemic attack transient | MNDR-E-MI-01237 |
| MNDR | hsa-let-7d-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-01238 |
| MNDR | hsa-let-7d-5p | Familial ovarian cancer | MNDR-E-MI-01239 |
| MNDR | hsa-let-7d-5p | Prostate adenocarcinoma | MNDR-E-MI-01240 |
| MNDR | hsa-let-7d-5p | Carcinoma ductal breast | MNDR-E-MI-01241 |
| MNDR | hsa-let-7d-5p | Glioblastoma | MNDR-E-MI-01242 |
| MNDR | hsa-let-7d-5p | Glioma | MNDR-E-MI-01243 |
| MNDR | hsa-let-7d-5p | Chordoma | MNDR-E-MI-01244 |
| MNDR | hsa-let-7d-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-01245 |
| MNDR | hsa-let-7d-5p | Osteosarcoma | MNDR-E-MI-01246 |
| MNDR | hsa-let-7d-5p | Liposarcoma | MNDR-E-MI-01247 |
| MNDR | hsa-let-7d-5p | Meningioma | MNDR-E-MI-01248 |
| MNDR | hsa-let-7d-5p | Liver cancer | MNDR-E-MI-01249 |
| MNDR | hsa-let-7d-5p | Uterine cancer | MNDR-E-MI-01250 |
| MNDR | hsa-let-7d-5p | Cervical adenocarcinoma | MNDR-E-MI-01251 |
| MNDR | hsa-let-7d-5p | Lung squamous cell carcinoma | MNDR-E-MI-01252 |
| MNDR | hsa-let-7d-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-01253 |
| MNDR | hsa-let-7d-5p | Lung adenocarcinoma | MNDR-E-MI-01254 |
| MNDR | hsa-let-7d-5p | Adrenocortical cancer | MNDR-E-MI-01255 |
| MNDR | hsa-let-7d-5p | Thyroid carcinoma | MNDR-E-MI-01256 |
| MNDR | hsa-let-7d-5p | Tuberculosis | MNDR-E-MI-01257 |
| MNDR | hsa-let-7d-5p | Bladder urothelial carcinoma | MNDR-E-MI-01258 |
| MNDR | hsa-let-7d-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-01259 |
| MNDR | hsa-let-7d-5p | Renal clear cell carcinoma | MNDR-E-MI-01260 |
| MNDR | hsa-let-7d-5p | Biliary tract cancer | MNDR-E-MI-01261 |
| MNDR | hsa-let-7d-5p | Cholangiocarcinoma | MNDR-E-MI-01262 |
| MNDR | hsa-let-7d-5p | Esophageal cancer | MNDR-E-MI-01263 |
| MNDR | hsa-let-7d-5p | Lung small cell carcinoma | MNDR-E-MI-01264 |
| MNDR | hsa-let-7d-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-01265 |
| MNDR | hsa-let-7d-5p | Fibromyalgia | MNDR-E-MI-01266 |
| MNDR | hsa-let-7d-5p | Adenoma | MNDR-E-MI-01267 |
| MNDR | hsa-let-7d-5p | Breast invasive carcinoma | MNDR-E-MI-01268 |
| MNDR | hsa-let-7d-5p | Early hepatocellular carcinoma | MNDR-E-MI-01269 |
| MNDR | hsa-let-7d-5p | Familiar ovarian carcinoma | MNDR-E-MI-01270 |
| MNDR | hsa-let-7d-5p | B-cell lymphoma | MNDR-E-MI-01271 |
| MNDR | hsa-let-7d-5p | Rheumatoid arthritis | MNDR-E-MI-01272 |
| MNDR | hsa-let-7d-5p | T-cell leukemia | MNDR-E-MI-01273 |
| MNDR | hsa-let-7d-5p | Retinoblastoma | MNDR-E-MI-01274 |
| MNDR | hsa-let-7d-5p | Neuroblastoma | MNDR-E-MI-01275 |
| MNDR | hsa-let-7d-5p | Hodgkin lymphoma | MNDR-E-MI-01276 |
| MNDR | hsa-let-7d-5p | Burkitt lymphoma | MNDR-E-MI-01277 |
| MNDR | hsa-let-7d-5p | Tonsil cancer | MNDR-E-MI-01278 |
| MNDR | hsa-let-7d-5p | Acute myelocytic leukemia | MNDR-E-MI-01279 |
| MNDR | hsa-let-7d-5p | Colorectal cancer | MNDR-E-MI-01280 |
| MNDR | hsa-let-7d-5p | Nasopharynx carcinoma | MNDR-E-MI-01281 |
| MNDR | hsa-let-7d-5p | Multiple myeloma | MNDR-E-MI-01282 |
| MNDR | hsa-let-7d-5p | Nasopharyngeal cancer | MNDR-E-MI-01283 |
| MNDR | hsa-let-7d-5p | Prostatic neoplasms | MNDR-E-MI-01284 |
| MNDR | hsa-let-7d-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-01285 |
| MNDR | hsa-let-7d-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-01286 |
| MNDR | hsa-let-7d-5p | Breast cancer her3+ negative | MNDR-E-MI-01287 |
| MNDR | hsa-let-7d-5p | High grade dysplastic nodule | MNDR-E-MI-01288 |
| MNDR | hsa-let-7d-5p | Tubulovillous adenoma | MNDR-E-MI-01289 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABT1 | Homo sapiens | RR00027895 |
TOP